epirubicin has been researched along with Hepatic Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, B; Liang, SN; Liu, LL; Su, HY; Xu, K; Zhao, GS | 1 |
| Armillotta, N; Bartolozzi, C; Cicorelli, A; Cioni, D; Di Giulio, M; Donati, F; Lencioni, R; Moretti, M; Paolicchi, A; Pinto, F | 1 |
2 other study(ies) available for epirubicin and Hepatic Failure
| Article | Year |
|---|---|
[Analysis of severe complications after transcatheter arterial chemoembolization for primary hepatocellular carcinoma].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Fluorouracil; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Iodized Oil; Liver Failure; Liver Neoplasms; Male; Middle Aged; Mitomycin; Pulmonary Embolism; Young Adult | 2008 |
Combined transcatheter arterial chemoembolization and percutaneous ethanol injection for the treatment of large hepatocellular carcinoma: local therapeutic effect and long-term survival rate.
Topics: Actuarial Analysis; Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Catheterization, Peripheral; Chemoembolization, Therapeutic; Disease Progression; Epirubicin; Ethanol; Female; Follow-Up Studies; Humans; Injections, Intralesional; Liver Cirrhosis; Liver Failure; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Remission Induction; Survival Rate; Tomography, X-Ray Computed | 1998 |